RNASEL and cancer: Though mutations in RNase L have been implicated in various cancers, only mutations at position 3 (in repeats 7 and 8) have been shown with reduced 2–5 A binding activity and complete loss of binding activity, when mutations are presented at both the 240 and 274 position in the protein.